0001562180-21-000307.txt : 20210112
0001562180-21-000307.hdr.sgml : 20210112
20210112164838
ACCESSION NUMBER: 0001562180-21-000307
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210108
FILED AS OF DATE: 20210112
DATE AS OF CHANGE: 20210112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Christmas Patrick J.
CENTRAL INDEX KEY: 0001521123
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37553
FILM NUMBER: 21524021
MAIL ADDRESS:
STREET 1: C/O REGENXBIO INC.
STREET 2: 9600 BLACKWELL ROAD, SUITE 210
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENXBIO Inc.
CENTRAL INDEX KEY: 0001590877
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 471851754
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9600 BLACKWELL ROAD
STREET 2: SUITE 210
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 240-552-8181
MAIL ADDRESS:
STREET 1: 9600 BLACKWELL ROAD
STREET 2: SUITE 210
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: REGENXBIO, Inc.
DATE OF NAME CHANGE: 20150116
FORMER COMPANY:
FORMER CONFORMED NAME: ReGenX Biosciences, LLC
DATE OF NAME CHANGE: 20131101
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2021-01-08
false
0001590877
REGENXBIO Inc.
RGNX
0001521123
Christmas Patrick J.
C/O REGENXBIO INC.
9600 BLACKWELL ROAD, SUITE 210
ROCKVILLE
MD
20850
false
true
false
false
Chief Legal Officer
Common Stock
2021-01-08
4
M
false
10000.00
12.10
A
26372.00
D
Common Stock
2021-01-08
4
S
false
4618.00
46.43
D
21754.00
D
Common Stock
2021-01-08
4
S
false
4062.00
47.42
D
17692.00
D
Common Stock
2021-01-08
4
S
false
1320.00
48.13
D
16372.00
D
Common Stock
2021-01-11
4
M
false
7500.00
12.10
A
23872.00
D
Common Stock
2021-01-11
4
M
false
2622.00
19.50
A
26494.00
D
Common Stock
2021-01-11
4
S
false
10122.00
49.08
D
16372.00
D
Common Stock
2021-01-12
4
M
false
1378.00
19.50
A
17750.00
D
Common Stock
2021-01-12
4
S
false
1378.00
49.15
D
16372.00
D
Employee Stock Option (Right to Buy)
12.10
2021-01-08
4
M
false
10000.00
0.00
D
2026-08-17
Common Stock
10000.00
29931.00
D
Employee Stock Option (Right to Buy)
12.10
2021-01-11
4
M
false
7500.00
0.00
D
2026-08-17
Common Stock
7500.00
22431.00
D
Stock Option (Right to Buy)
19.50
2021-01-11
4
M
false
2622.00
0.00
D
2027-01-03
Common Stock
2622.00
2019.00
D
Stock Option (Right to Buy)
19.50
2021-01-12
4
M
false
1378.00
0.00
D
2027-01-03
Common Stock
1378.00
641.00
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan.
This transaction was executed in multiple trades at prices ranging from $45.86 to $46.84. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $46.87 to $47.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $47.87 to $48.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $49.00 to $49.42. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $49.00 to $49.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The previously granted option, representing a right to purchase a total of 125,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on August 18, 2017, and the balance vested in equal monthly installments over the 36 months thereafter.
The previously granted option, representing a right to purchase a total of 11,100 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 4, 2018, and the balance vested in equal monthly installments over the 36 months thereafter.
/s/ Patrick J. Christmas
2021-01-12